483 Xellia Pharmaceuticals USA Jun 2006

483 Xellia Pharmaceuticals USA Jun 2006

Carolyn Renshaw FDA, Gang Wang FDA$119.00 - Available Now

FDA investigators audited the Xellia Pharmaceuticals USA - Raleigh, NC, United States facility and issued inspectional observations (via FDA 483) on 02 Jun 2006.

Product details

  • Category: Biologics / Human Drugs
  • Inspection end: 02 Jun 2006
  • Location: Raleigh, United States
  • FEI: 3005208599
Add To Cart